Appraisal in progress
Indication |
|
Status: In progress | |
For the treatment of patients with moderate to severe pemphigus vulgaris. |
|
Medicine details |
|
Medicine name | rituximab (MabThera®) |
Formulation | 100mg concentrate for solution for infusion, 500mg concentrate for solution for infusion |
Reference number | 3192 |
Indication | As above |
Company | Roche Products Ltd |
BNF chapter | Skin |
Submission type | Directed |
Status | In progress |
NMG meeting date | 06/07/2022 |
AWMSG meeting date | 14/09/2022 |
Date of issue | TBC |